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Abstract
Japanese encephalitis (JE) is a global public health issue that has spread widely to more than 20 countries in Asia and has
extended its geographic range to the south Pacific region including Australia. JE has become the most important cause of
viral encephalitis in the world. Japanese encephalitis viruses (JEV) are divided into five genotypes, based on the nucleotide
sequence of the envelope (E) gene. The Muar strain, isolated from patient in Malaya in 1952, is the sole example of genotype
V JEV. Here, the XZ0934 strain of JEV was isolated from Culex tritaeniorhynchus, collected in China. The complete nucleotide
and amino acid sequence of XZ0934 strain have been determined. The nucleotide divergence ranged from 20.3% to 21.4%
and amino acid divergence ranged from 8.4% to 10.0% when compared with the 62 known JEV isolates that belong to
genotype I–IV. It reveals low similarity between XZ0934 and genotype I–IV JEVs. Phylogenetic analysis using both complete
genome and structural gene nucleotide sequences demonstrates that XZ0934 belongs to genotype V. This, in turn, suggests
that genotype V JEV is emerging in JEV endemic areas. Thus, increased surveillance and diagnosis of viral encephalitis
caused by genotype V JEV is an issue of great concern to nations in which JEV is endemic.
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Introduction
Japanese encephalitis (JE), which is caused by JE virus (JEV), is one
of the most important viral encephalitis in the world [1–4]. It is
prevalent mostly in Asia including eastern Asia [5–7], southern Asia
[8] and southeastAsia[9,10]. JE has extended its geographic range to
the south Pacific region, including Australia [11,12]. An estimated 3
billion persons live in countries where JE is endemic [1–3].
JEV has a zoonotic transmission cycle between mosquitoes
(principally of the genus Culex) and vertebrate hosts such as bats,
water birds and pigs [1,4]. Human beings contract JEV when
bitten by infected mosquitoes. Around 35,000–50,000 JE cases are
reported each year, of which 10,000–15,000 are fatal [1–3,13].
Approximately 50% of JE patients present severe neurological and
mental sequelae such as motor deficits, and cognitive and language
impairment [14–16].
JEV is a member of the genus Flavivirus, family Flaviviridae [1].
Like other flaviviruses, the JEV genome is a single-stranded
positive-sense RNA of approximately 11 kb in length. It is capped
at its 59 end and has a single open reading frame (ORF) that
encodes a polyprotein. The ORF is flanked by 59 and 39
untranslated regions (UTRs). The viral structural proteins are
encoded by the 59 one-third of the ORF and consist of the capsid
(C), membrane (M; formed by proteolytic cleavage of its precursor
protein PrM) and envelope (E) proteins. The remaining 39 region
encodes non-structural proteins (NS1 to NS5) [1,17].
JEVs have been divided into five genotypes (genotype I, II, III,
IV, V), based on nucleotide sequence of E gene [18]. Genotypes
I-IV have been isolated from many vectors [19–21], bats [22], and
patients [7,8,21,23,24] in Asia (including eastern, southern and
southeast Asia) and Australia. To date, the Muar strain, which was
isolated from specimens of brain tissues of patients with viral
encephalitis in Malaya in 1952, is the only example of genotype V
JEV[18,25].Sincethattime,nogenotypeVJEVhasbeendetected.
Inthisstudy,genotypeV JEVwasisolatedfromCulex tritaeniorhynchus
collected in China in 2009. This suggests that genotype V JEV is re-
emerging in Asian country after a 57 year hiatus.
Materials and Methods
Cell cultures
C6/36 (Aedes albopictus) cell line was grown in minimal essential
medium (HyClone) with Hanks’ salt solution supplemented with
10% fetal bovine serum (FBS, HyClone), 2 mM glutamine, 0.12%
NaHCO3, and 100 U ml
21 penicillin and streptomycin. Cells
were propagated and maintained at 28uC [21]. BHK-21 cells were
grown in minimal essential medium (HyClone) with Earl’s
balanced salt solution supplemented with 10% FBS, 2 mM
glutamine, 0.12% NaHCO3, and 100 U ml
21 penicillin and
streptomycin. BHK-21 cells were propagated and maintained at
37uC under a 5% CO2 atmosphere [21].
Mosquito collection
An arbovirus survey was conducted in Tibet in the summer of
2009. Mosquitoes were collected in Mainling County (altitude
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area of Tibet. Mosquito samples were collected using mosquito-
trapping lamps (Wuhan Lucky Star Environmental Protection
Tech Co., Ltd., Hubei, China) in the evening. Collection locations
were proximal to sites of frequent human activity. Collection nets
containing mosquitoes were frozen for 30 min at 220uC and
transferred onto an ice plate for determination of mosquito species
(blood-fed and male mosquitoes were discarded). Female mosqui-
toes were identified to species level by morphologic characteristics
and sorted into pools of 100 specimens according to species. The
pools were put into collection tubes individually and stored in
liquid nitrogen [26,27].
Virus isolation
Mosquito pools were added to 1.5 ml minimal essential medium
(HyClone), supplemented with 2 mM glutamine, 0.12%
NaHCO3, and 100 U ml
21 penicillin and streptomycin, followed
by grinding in a pre-cooled sterile plastic grinding tube using a
TissueLyser (GIAGEN, Germany). Homogenized samples were
centrifuged at 17,0006g in a microcentrifuge for 20 min at 4uC,
and the clarified supernatants were used to inoculate monolayers
of BHK-21 and C6/36 cells and incubated at 37uC and 28uC,
respectively. The cells were observed daily to check for
development of cytopathic effects (CPE). A sample was regarded
as virus-positive if it caused CPE in successive cell passages
[26,27].
Virus purification
Viral supernatants were applied to six-well plates (Corning,
USA) of confluent BHK-21 cells and incubated for one hour.
Plates were first overlaid with medium containing 75% agarose
and then with medium containing neutral red vital stain after three
days incubation at 37uC in a 5% CO2 incubator. Plaques of
different sizes and shape were shattered in 500 ul MEM medium
after being picked out using a sterile pipette tip. As described
previously [28], this process was repeated until a single plaque-
shaped virus was obtained.
RNA extraction, reverse transcription and PCR
amplification
Viral RNA was extracted from 140 ul supernatant from virus-
infected BHK-21 cell cultures using a Viral RNA Mini Kit
(QIAGEN, Germany) according to the manufacturer’s instruc-
tions. cDNA was synthesized using a Ready-to-Go You-Prime
First-Strand Beads Kit (GE healthcare, UK) and random
hexanucleotide primers. PCR amplification using universal
primers specific for flaviviruses, alphaviruses and bunyaviruses
was conducted for identification of virus isolates [29]. Primers
(Table 1) were designed for full-length genome amplification and
sequencing of JEV using the PREMIER Primer 5 software
package. Thermal cycling parameters were as follows: one cycle of
denaturation (94uC, 5 min) followed by 35 cycles of 94uC
denaturation for 30 s, 55uC annealing for 30 s, and 72uC
extension for 1 min. The programme ended with an extension
step at 72uC for 10 min. Amplified products were examined by
agarose gel electrophoresis (1%), purified using a QIAquick Gel
Extraction kit (QIAGEN, Germany), and then sequenced directly.
Sequencing of the 59 UTR and 39 UTR were determined by using
59 RACE and 39 RACE system for Rapid Amplification of cDNA
Ends (Invitrogen) respectively. 59 RACE was performed according
to standard protocols (Invitrogen 59 RACE kit). 39 RACE was
performed by first adding a polyA tail using PolyA polymerase
(New England Biolabs) and then conduct RT-PCR with gene
specific primers and an oligo-dT-adapter primer.
Multiple alignments and sequence analyses
The full-length genome of the XZ0934 strain was compiled using
SeqMan in the Lasergene software package (DNASTAR). Nucle-
otide and amino acid sequence alignments were generated by
ClustalX version 2.0.9 [22,30]. Analysis of nucleotide and deduced
Table 1. Primers used for RT-PCR and sequencing of XZ0934
in this study.
Primer Sequence (59–39) Position Orientation
JEV-V-1 AGAAGTTTATCTGTGTGAACT 1–21 Sense
JEV-V-2 CACAAGAGCATAGCCTGGAT 868–887 Antisense
JEV-V-3 AGGGACTAATAGATGTTGGG 563–582 Sense
JEV-V-4 TCAGAGTGATGGAAGGAG 1495–1512 Antisense
JEV-V-5 GCGAACGACAAACCAACA 1080–1097 Sense
JEV-V-6 GACGTAATGCCAAACCCA 2951–2968 Antisense
JEV-V-7 GCCATTGACATAACCAGAA 2490–2508 Sense
JEV-V-8 ATCAAGGCCAAATGAACT 3755–3772 Antisense
JEV-V-9 ATACGGCCCATGAAGCAT 3480–3497 Sense
JEV-V-10 CTCGAGCCATTATCCTGTA 4674–4692 Antisense
JEV-V-11 GGCCATCATCCCAGCAGCT 4553–4571 Sense
JEV-V-12 CCTCTAAGAGCTTCTGCCAT 5301–5320 Antisense
JEV-V-13 AACAGCTGTTCTAGCGCC 5261–5278 Sense
JEV-V-14 CCATTGTGAAAGCCTTCTCC 6149–6168 Antisense
JEV-V-15 AGAGTAGGCAGAAATCCGAA 5988–6007 Sense
JEV-V-16 GAGGCTAGTGATGTTGTCAC 7107–7126 Antisense
JEV-V-17 GATGCAACGAAAGGGCATAG 6677–6696 Sense
JEV-V-18 TGAGACAAACCCTTTCTCCA 7876–7895 Antisense
JEV-V-19 CCTGTGGGATAATGGAGC 7538–7555 Sense
JEV-V-20 TTGGTGGTTTCGTCCAGCAC 8802–8821 Antisense
JEV-V-21 AATGTACTGGGTTAGTGG 8333–8350 Sense
JEV-V-22 CTTACGTCGGCCTGACTCCC 10465–10484 Antisense
JEV-V-23 CAAATGTGGCTCCTCCTCT 9972–9990 Sense
JEV-V-24 AGATCCTGTGTTCTTCCTCA 10964–10983 Antisense
doi:10.1371/journal.pntd.0001231.t001
Author Summary
Japanese encephalitis virus (JEV) is a mosquito-borne virus
that causes Japanese encephalitis (JE) with significant
morbidity and mortality. Five genotypes (genotype I–V)
have been identified based on the nucleotide sequence of
viral envelope (E) gene of JEV. To date, the only known
strain of genotype V is Muar strain, isolated from patient in
Malaya in 1952. Since then, no genotype V JEV has been
detected in the world. In this study, the JEV strain, XZ0934,
was isolated from mosquito samples collected in China in
2009. The full-length genome sequences of the XZ0934
strain was determined and founded to be the second
strain of genotype V JEV based on the phylogenetic
analysis using the complete genome and structural gene
sequences. This suggests that genotype V JEV is re-
emerging after 57 years (1952–2009). Therefore, increased
surveillance and more effective diagnosis for cases of JE
caused by genotype V JEV are needed.
Isolation and Identification of Genotype V JEV
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MegAlign in the Lasergene software package (DNASTAR).
Phylogenetic analysis
Full-length nucleotide sequences of 32 selected JEV strains of
varying genotype isolated from different locations and sources, and
across a number of years, were downloaded from GenBank
(Table 2). The reported structural gene sequence of genotype V
JEV (Muar strain) [25] was used to build phylogenetic trees.
Neighbor-joining phylogenetic trees based on nucleotide sequenc-
es were constructed using MEGA version 4.0.2 [18,31]. The
robustness of phylogenetic constructions was evaluated by boot-
strapping using 1000 replicates.
To better understand the phylogenetic relationship between
genotype V JEV and other flaviviruses, full-length nucleotide
sequences of previously published JEV strains and other flaviviruses
were downloaded from GenBank, including sequences from Murray
Valley encephalitis virus (MVEV), West Nile virus (WNV), Kunjin
virus (KUNV), St. Louis encephalitis virus (SLEV), Dengue virus 1
(DENV1, Dengue virus 2 (DENV2), Dengue virus 3 (DENV3),
Dengue virus 4 (DENV4), Yellow fever virus (YFV), Powassan virus
(POWV), Langat virus (LANV), Louping ill virus (LIV), Tick-borne
encephalitis virus (TBEV) and Culex flavivirus (Table 3).
Results
Virus isolation and purification
After homogenized supernatants were inoculated onto monolayers
of BHK-21 and C6/36 cells, a single pool containing 100 specimens
of Culex tritaeniorhynchus yielded a virus isolate designated XZ0934.
The supernatant of pool XZ0934 caused cytopathic effects (CPE) in
BHK-21 and C6/36 cells in successive cell passages. The C6/36 cells
became aggregate, and showed fusion and shedding while the BHK-
21 cells became aggregate and began shedding by 72 h post-
infection. All plaques in BHK-21 cell monolayers were of identical
size (mean 1.5 mm,n=10). Two plaques werepicked from them and
subjected to a second round of plaque purification. The resultant data
were consistent with the former.
Table 2. Background information of 32 selected strains of Japanese encephalitis virus used in this study.
No. Genotype Strain Year Location Source GenBank accession no.
1 I K94P05 1994 Korea Mosquito AF045551
2 I KV1899 1999 Korea Pig AY316157
3 I Ishikawa 1998 Japan Mosquito AB051292
4 I JEV/sw/Mie/41/2002 2002 Japan Pig AB241119
5 I JEV/sw/Mie/40/2004 2004 Japan Pig AB241118
6 I SC04-17 2004 China Mosquito GU187972
7 I HEN0701 2007 China Pig FJ495189
8 I XJ69 2007 China Mosquito EU880214
9 I XJP613 2007 China Mosquito EU693899
10 I SH17M-07 2007 China Mosquito EU429297
11 I JX61 2008 China Pig GU556217
12 II FU 1995 Australia Human AF217620
13 III Vellore P20778 1958 India Human AF080251
14 III GP78 1978 India Human AF075723
15 III 014178 2001 India Human EF623987
16 III 04940-4 2002 India Mosquito EF623989
17 III 057434 2005 India Human EF623988
18 III Nakayama 1935 Japan Human EF571853
19 III JaGAr01 1959 Japan Mosquito AF069076
20 III JaOH0566 1966 Japan Human AY508813
21 III JaOArS982 1982 Japan Mosquito M18370
22 III K87P39 1987 Korea Mosquito AY585242
23 III p3 1949 China Human U47032
24 III Beijing-1 1949 China Human L48961
25 III SA14-14-2 1954 China Vaccine strain AF315119
26 III HW 1988 China Pig AY849939
27 III WHe 1988 China Pig EF107523
28 III SH0601 2006 China Pig EF543861
29 III Ling 1965 Taiwan Human L78128
30 III CH1392 1990 Taiwan Mosquito AF254452
31 III T1P1 1997 Taiwan Mosquito AF254453
32 IV JKT6468 1981 Indonesia Mosquito AY184212
doi:10.1371/journal.pntd.0001231.t002
Isolation and Identification of Genotype V JEV
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Viral RNA was extracted and amplified by PCR using primers
specific for flaviviruses, alphaviruses and bunyaviruses. XZ0934
was positive when primers specific for flaviviruses (FU1/cFD2)
[29] were used, and nucleotide sequencing confirmed that
XZ0934 was a JEV. To ensure the consistency of different viral
plaques, six purified plaques were picked and amplified using
flavivirus-specific primers (FU1/cFD2). The nucleotide and amino
acid sequence identities of the six purified plaques were 100%.
This indicates that each of the six purified plaques was generated
by an identical JEV strain. Therefore, one plaque was selected for
full-length genome amplification and sequencing.
Determination of viral genome sequence
Recent reports have suggested that JEVs currently circulating in
China belong to genotypes I and III [5–7,21–23]. Thus, 32
primers were designed using the complete sequences of genotype I
JEV Ishikawa (GenBank accession number AB051292) and 48
from the sequence of genotype III JEV Beijing-1 (GenBank
accession number L48961). These were used for amplification of
the entire XZ0934 genome. PCRs were positive with 4 genotype I
and 10 genotype III primers. Based on obtained nucleotide
sequences, primers were designed to close the majority of gaps
between assembled contigs by PCR amplification in order to
determine the whole genome of XZ0934. A further 24 primers
(Table 1) were designed and used to verify the accuracy of
sequencing. The complete genome (10,983 nt) of XZ0934 was
sequenced (GenBank accession no. JF915894) and found to
possess one open reading frame (ORF). When the complete
genome sequence of isolate XZ0934 was compared with those of
62 known JEV isolates (genotypes I–IV) in Genbank, sequence
identities varied from 78.6% (KV1899, K94P05) to 79.7% (CC27-
L1) and amino acid sequence identity from 90.0% (KV1899,
K94P05) to 91.6% (K87P39). Thus, these data reveal low
similarity between XZ0934 and genotype I–IV JEVs.
Because the structural gene sequence of genotype V (Muar) has
been reported [25], an identity analysis of JEV structural genes (C,
PrM, M, E) of XZ0934, Muar and other selected genotype I–IV
JEV strains was conducted (Table 4). C gene sequence homology
varied from 78.2% (G IV, JKT 6468) to 88.5% (G V, Muar) for
nucleotides and 72.4% (G IV, JKT 6468) to 85.8% (G V, Muar)
for amino acids. That of the PrM gene varied from 71.7% (G IV,
JKT 6468) to 84.1% (G V, Muar) for nucleotides and 81.5% (G
IV, JKT 6468) to 90.2% (G V, Muar) for amino acids. M gene
sequence homology varied from 80.0% (G IV, JKT 6468) to
95.6% (G V, Muar) for nucleotides and 85.3% (G IV, JKT 6468)
to 100.0% (G V, Muar) for amino acids. E gene sequence
homology varied from 77.0% (G I, Ishikawa) to 86.0% (G V,
Muar) for nucleotides and 89.4% (G I, Ishikawa) to 93.2% (G V,
Muar) for amino acids. These data demonstrate that the structural
Table 3. Background information of 14 selected strains of Flaviviruses used in this study.
Virus Strain GenBank accession no.
Murray Valley encephalitis virus (MVEV) MVE-1-51 NC_000943
West Nile virus (WNV) ArB3573/82 DQ318020
Kunjin virus (KUNV) MRM61C D00246
St. Louis encephalitis virus (SLEV) Kern217 DQ525916
Dengue virus 1 (DENV1) SG(EHI)D1227Y03 FJ469909
Dengue virus 2 (DENV2) D2/SG/05K4155DK1/2005 EU081180
Dengue virus 3 (DENV3) D3/H/IMTSSA-MART/1999/1243 AY099337
Dengue virus 4 (DENV4) 341750 GU289913
Yellow fever virus (YFV) 17D/Tiantan FJ654700
Powassan virus (POWV) Spassk-9 EU770575
Langat virus (LANV) TP21 NC_003690
Louping ill virus (LIV) 369/T2 NC_001809
Tick-borne encephalitis virus (TBEV) Toro-2003 DQ401140
Culex flavivirus Tokyo AB262759
doi:10.1371/journal.pntd.0001231.t003
Table 4. Sequence homology between XZ0934 and five genotype JEV strains in structural gene.
Genotype Strain Percentage homology of nucleotides (amino acids)
CP r M M E
G I Ishikawa (AB051292) 79.5% (77.2%) 78.3% (87.0%) 84.0% (93.3%) 77.0% (89.4%)
G II FU (AF217620) 81.4% (78.7%) 74.3% (84.8%) 81.8% (94.7%) 77.5% (90.6%)
G III p3 (U47032) 81.4% (78.0%) 76.8% (85.9%) 83.6% (93.3%) 77.4% (90.2%)
G IV JKT 6468 (AY184212) 78.2% (72.4%) 71.7% (81.5%) 80.0% (85.3%) 77.5% (90.6%)
G V Muar (Hasegawa et al.(25)) 88.5% (85.8%) 84.1% (90.2%) 95.6% (100.0%) 86.0% (93.2%)
doi:10.1371/journal.pntd.0001231.t004
Isolation and Identification of Genotype V JEV
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JEV (Muar) than with other genotype I–IV JEV strains.
Phylogenetic analysis
To establish the phylogenetic relationship between XZ0934 and
other JEV strains, a phylogenetic tree was constructed using the
complete genome sequences of XZ0934 and 32 selected JEV
strains (genotypes I–IV). Murray Valley encephalitis virus (MVEV)
was used as an outgroup. Five distinct phylogenetic groups were
identified. The XZ0934 strain, which was isolated from China,
formed a branch divergent from other genotype I–IV JEV strains
(Figure 1A). Therefore, XZ0934 should be regarded as a novel,
non-genotype I–IV, JEV isolate.
To study their phylogenetic relationship, a phylogenetic tree was
constructed using the reported structural gene nucleotide sequences
of Muar [25], XZ0934, and other JEV strains (genotype I–IV). No
matter which structural gene was used to construct the phylogenetic
tree, the topology was similar. Five distinct phylogenetic groups
were evident in each tree. XZ0934 and Muar fell into the same
group when the tree was constructed using the C (Figure 1B), PrM
(Figure 1C), M (Figure 1D) or E (Figure 1E) genes. This result
suggested that XZ0934 was a novel genotype V JEV isolate.
A phylogenetic tree was also constructed using genomic nucleotide
sequences in order to understand the phylogenetic relationship
between XZ0934 and other flaviviruses. Data indicated that
XZ0934 was indeed a JEV rather than any of the other 14 flaviviruses
(Figure 2).
Discussion
In recent years, the sequence of the JEV viral envelope (E) gene
has been used by various authors to perform phylogenetic analyses
[18,21,32,33]. Based on the resultant data, JEV strains have been
divided into five genotypes (genotypes I-V) [18]. Genotypes I and
III are distributed widely in Asia, including Japan, Korea, China,
India, Vietnam and Philippines. Genotype II includes isolates from
southern Thailand, Malaysia, Indonesia, and northern Australia.
Genotype IV has been isolated only in Indonesia [18]. The Muar
strain, isolated in Malaya in 1952, is regarded as the only genotype
V JEV isolate [18,25,33]. In this study, phylogenetic analysis of
structural genes and whole genome sequences also suggested the
existence of five JEV genotypes. Thus, the E gene is confirmed to
be a useful phylogenetic marker for JEV.
Primers designed for JEV genotypes I and III were used for full-
length amplification of XZ0934. Of these, only a few (4/32
genotype I and 10/48 genotype III) resulted in successful
amplification. This suggests a low whole genome sequence
homology between XZ0934 and genotype I and I JEV isolates.
In order to further understand the differences between XZ0934
and other JEV strains (genotype I–IV), an identity analysis was
conducted using the full-length nucleotide sequences of XZ0934
and 62 known JEV isolates (genotypes I–IV) in Genbank. Data
suggested that XZ0934 and the genotype I–IV JEV strains were
dissimilar. The nucleotide sequence identity varied from 78.6% to
79.7% and amino acid sequence identity from 90.0% to 91.6%.
Indeed, the sequence divergence ranged from 20.3% to 21.4% (nt)
and 8.4%–10.0% (aa). It has been suggested that the nucleotide
sequence divergence between different JEV genotypes is ,10%
[13]. The sequence divergence (20.3%–21.4%) between XZ0934
and the genotype I–IV JEVs was greater than 10%, suggesting
that XZ0934 is not a member of JEV genotypes I–IV. To confirm
that XZ0934 was a JEV and not some other flavivirus, 14
flavivirus strains, including mosquito-borne and tick-borne
flaviviruses, were used to build a phylogenetic tree. The data
indicated that XZ0934 was indeed a JEV (Fig. 2).
Figure 1. Phylogenetic analysis of XZ0934 and other JEV strains based on the nucleotide sequences. A) complete genome; B) C gene; C)
PrM gene; D) M gene; E) E gene. Phylogenetic analyses were performed by the neighbor-joining method using MEGA version 4.0.2 software package
(www.megasoftware.net). The tree was rooted using Murray Valley encephalitis virus (MVEV) strain MVE-1-51 as an outgroup. Bootstrap probabilities
of each node were calculated using 1000 replicates. Scale bars indicate the number of nucleotide substitutions per site.
doi:10.1371/journal.pntd.0001231.g001
Figure 2. Phylogenetic analysis of XZ0934 and other flaviviruses constructed using complete genome sequences. Phylogenetic
analyses were performed by the neighbor-joining method using MEGA version 4.0.2 software package (www.megasoftware.net). Bootstrap
probabilities of each node were calculated using 1000 replicates. Scale bars indicate the number of nucleotide substitutions per site.
doi:10.1371/journal.pntd.0001231.g002
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and Singapore (n=3) in the summer of 1952. All patients
exhibited high fever, vomiting, headache, disturbance of con-
sciousness, stiff neck and deep coma with rapid progression to
death by respiratory failure. Four virus strains were isolated from
brain tissue specimens and identified as JEV by neutralization test
using the Japanese Nakayama JEV strain [24]. Of these, the Muar
strain, isolated from a 19-year-old male patient in Malaya in 1952,
has been assigned to genotype V based on the E gene sequence
[18,25,32,33]. During the following 57 years (1952–2009), no
genotype V JEV has been reported. In this study, XZ0934,
isolated from Culex tritaeniorhynchus collected in China, has been
identified as a genotype V JEV, based on phylogenetic analysis
using both full-length genome and structural gene nucleotide
sequences. This represents only the second instance of isolation of
genotype V JEV worldwide since 1952. Thus, genotype V JEV is
not limited to southeast Asia and has begun to be emerge in the
world.
Many factors may contribute to spread of JEV [1,2], such as
changed agricultural practices (which provide new breeding sites
for mosquitoes), animal husbandry (which provides host animals
for transmission) [34], migrating birds and even wind-blown
mosquitoes [11,35]. Each of the five known JEV genotypes
originated in the Indonesia-Malaysia region [18], so why has
genotype V JEV not been detected for 57 years? How did it spread
to China from southeast Asia, a distance of thousands of
kilometers? Does this virus exist somewhere along the path from
Malaysia to China? All these issues are worthy of further study.
Moreover, genotype V JEV was first isolated from human
specimens, suggesting a high pathogenicity and the possibility of
viral encephalitis. Therefore, increased surveillance and more
effective diagnosis of viral encephalitis caused by genotype V JEV
is an issue of great concern to nations in which JEV is endemic.
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